Azur Pharma

19 results

Avectas cofounder and chief executive Dr Michael Maguire, with cofounder Dr Shirley O’Dea, chief scientific officer and business development director Dr Gillian Hendy. Photograph: Iain White/Fennells

Serial entrepreneur Seamus Mulligan has led a $10 million (€12 million) fundraising for an Irish business at the cutting edge of cell therapy. Avect(...)

Smurfit Kappa chief executive Tony Smurfit. Photograph: Brenda Fitzsimons

From promising acquisitions to significant asset sales and business exits, the winners for July, August and September of this year’s Irish Times Busin(...)

Aryzta had an unremitting bad year and was the  standout corporate loser of 2018. Photograph: Reuters

It was another year of mixed fortunes in corporate Ireland. The economy continues to be the fastest growing in Europe while the live register fell to (...)

Séamus Mulligan, chairman and chief executive of Adapt Pharma

Séamus Mulligan, the chairman and chief executive of Adapt Pharma, has been chosen as The Irish Times Business Person of the Month for August, an awar(...)

Adapt Pharma developed a non-injectable form of Naloxone,  which resulted in a $735 million payday for its investors,  including serial pharmaceutical entrepreneur Séamus Mulligan

You’d never say that a $735 million payday was not a landmark occasion but the sale of Adapt Pharma – the maker of the opioid rescue drug Narcan that (...)

Two members of the Manchester fire department in New Hampshire assess the condition of a man who had overdosed on heroin and who was revived with two doses of Narcan. Photograph: Don Emmert/AFP/Getty Images

In hindsight, it looks like a no-brainer. Take a tried and tested drug that addresses a burgeoning epidemic and make it easier to use. Then sit back a(...)

An overdose rescue kit featuring nasal spray and injectable Naloxone at a demonstration in New York. File photograph: Getty Images

Six Irish businessmen will share a $635 million (€542m) payday after selling a company that developed a drug used in the frontline as the United State(...)

Bruce Cozadd, chief executive and chairman of Jazz Pharmaceuticals, which saw its shares fall more than 6 per cent overnight as it lowered full-year guidance. Photograph: Dara Mac Dónaill

Shares in Irish orphan drug group Jazz Pharmaceuticals fell more than 6 per cent per cent overnight as it lowered earnings guidance for the full year.(...)

Taoiseach Enda Kenny and Bruce Cozadd, chairman and chief executive of Jazz Pharmaceuticals. Photograph: Shane O’Neill/Fennells

Irish specialty pharma group Jazz has been selected as one of banking giant Barclays stock picks for 2017. The shares, which dipped 20 per cent on th(...)

Waterford Distillery undertook its first distillation in December. It is aiming to distil 1 million litres of spirits this year, increasing this to 3 million litres within five years

A company led by the man behind the renaissance of the highly regarded Scottish whisky distillery Bruischladdich, spent just €7.2 million to acquire a(...)

  • 1
  • 2
  • Next
  • Last »